SEC Filing Details

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

SEC Filing Details

Document Details

Filing Date
Feb 10, 2021
Document Date
Feb 10, 2021
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Luminex Corporation
Issuer
LUMINEX CORP

Shareholder Tools